Baltic Dental and Maxillofacial Journal | ||||||||||
March, 2016, Vol. 18, No. 1 CONTENTS REVIEW SCIENTIFIC ARTICLES CASE REPORT
© 2016 Stomatologija |
Stomatologija 2016; 18 (1): 9-13 528 KB Hypericum perforatum L. treatment restored bone mass changes in swimming stressed rats Nikos Seferos, Loukas Petrokokkinos, Antonia Kotsiou, George Rallis, Christine Tesseromatis Summary Stress, via corticosteroids release, influences bone mass density. Hypericum perforatum (Hp) a traditional remedy possess antidepressive activity (serotonin reuptake inhibitor) and wound healing properties. Hp preparation contains mainly hypericin, hyperforin, hyperoside and flavonoids exerting oestrogen-mimetic effect. Cold swimming represents an experimental model of stress associating mental strain and corporal exhaustion. Objectives. This study investigates the Hp effect on femur and mandible bone mass changes in rats under cold forced swimming procedure. Methods. 30 male Wistar rats were randomized into three groups. Group A was treated with Methanolic extract of Hp (Jarsin®) via gastroesophageal catheter, and was submitted to cold swimming stress for 10 min/daily. Group B was submitted to cold stress, since group C served as control. Experiment duration was 10 days. Haematocrite and serum free fatty acids (FFA) were estimated. Furthermore volume and specific weight of each bone as well as bone mass density via dual energy X-Ray absorptiometry (DEXA) were measured. Statistic analysis by t-test. Results. Hp treatment restores the stress injuries. Adrenals and bone mass density regain their normal values. Conclusions. Injuries occurring by forced swimming stress in the rats are significantly improved by Hp treatment. Estrogen-like effects of Hp flavonoids eventually may act favorable in bone remodeling. Key words: swimming stress, bone mass, Hypericum perforatum, rats. Received: 03 03 2014 Accepted for publishing: 28 03 2016 1Department of Pharmacology, Medical School, University of Athens, Greece 2Department of Medical Physics Lab, Medical School, University of Athens, Greece 3Aretaieion University Hospital, Athens, Greece 4Department of Oral and Maxillofacial Surgery, General Hospital of Athens "KAT", Greece Nikos Seferos1 – dental doctor Loukas Petrokokkinos2 – physicist, MSc Antonia Kotsiou3 – pharmacist, PhD, lecturer George Rallis4 – Dr. Med, Dr. Dent, PhD Christine Tesseromatis1 – MD, MDD, assoc. prof Address correspondence to Dr. Christine Tesseromatis, Department of Pharmacology, Medical School, University of Athens, Mikras Asias 75, Goudi 11527, Greece. E-mail address: ctesser@med.uoa.gr |
|||||||||